Clinical Trial Update: An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral enzalutamide in progressive metastatic prostate cancer has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Progressive Metastatic Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-04-12